LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY

V. Furer; T. Eviatar; D. Zisman; H. Peleg; D. Paran; D. Levartovsky; M. Zisapel; O. Elalouf; I. Kaufman; R. Meidan; A. Broyde; A. Polachek; J. Wollman; I. Litinsky; K. Meridor; H. Nochomovitz; A. Silberman; D. Rosenberg; J. Feld; A. Haddad; T. Gazitt; M. Elias; N. Higazi; F. Kharouf; G. Shefer; O. Sharon; S. Pel; S. Nevo; O. Elkayam

doi:10.1136/annrheumdis-2021-eular.5096

Citation Tools

PDF

Scientific Abstracts

Late breaking abstracts

Members and Volunteers – Unknown beings? How to explore their interests, establish contacts and support

LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Furer V, Eviatar T, Zisman D, et al

LB0003 IMMUNOGENICITY AND SAFETY OF THE BNT162b2 mRNA COVID-19 VACCINE IN ADULT PATIENTS WITH AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES AND GENERAL POPULATION: A MULTICENTER STUDY

Annals of the Rheumatic Diseases 2021;80:200-201.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password